订阅小程序
旧版功能

Tamuzimod in Patients with Moderately-to-severely Active Ulcerative Colitis: a Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Induction Trial

The Lancet Gastroenterology & Hepatology(2025)

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要